Axsome Therapeutics (AXSM) announced this morning that while the ACCORD-2 Phase 3 trial achieved the primary endpoint with AXS-05 statistically ...

ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse)ACCORD-2 Phase 3 ...

felix rummy "Wang Xingren" joins the anti-epidemic team! The detection rate of new coronavirus is as high as 94% Confirmed COVID-19! Pharmaceutical company employee infected Tecfidera loses patent ...

INR:3346. sijan 9 pro kabaddi A new target for Alzheimer's disease: Sgk1 The expansion of the 4+7 system has led to job turmoil for medical representatives He ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

Donald Frank was once a surprise NFL success story. Countless violent collisions left him with a neurocognitive impairment that's ravaged his memory.

A lawyer for the ex-Abercrombie & Fitch CEO charged with sex trafficking and prostitution says the former business leader has ...

Lawyers for Mike Jeffries, the former CEO of Abercrombie & Fitch, have questioned his ability to stand trial in a federal sex ...

A doctor who says he's as healthy as someone 20 years his junior believes walking is a key part of his daily routine.

Defense lawyers say the former longtime CEO of Abercrombie & Fitch may have dementia, and a competency hearing is necessary to determine if he can face sex charges.

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a mouse model of ...

The figure is expected to climb to more than half a million diagnoses by the end of 2024. The NHS is urging individuals to ...